These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12434455)

  • 41. Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance.
    Twardowski ZJ
    Blood Purif; 2007; 25(1):90-8. PubMed ID: 17170543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overutilization of central venous catheters in incident hemodialysis patients: reasons and potential resolution strategies.
    Lenz O; Sadhu S; Fornoni A; Asif A
    Semin Dial; 2006; 19(6):543-50. PubMed ID: 17150058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
    Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
    Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antihypertensive effect of low calcium dialysis.
    Katzir Z; Michlin A; Boaz M; Biro A; Smetana S
    Isr Med Assoc J; 2005 Nov; 7(11):704-7. PubMed ID: 16308992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency.
    Chandna SM; Kulinskaya E; Farrington K
    Nephrol Dial Transplant; 2005 Oct; 20(10):2130-8. PubMed ID: 15956057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent hemodialysis in children.
    Warady BA; Fischbach M; Geary D; Goldstein SL
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):297-303. PubMed ID: 17603985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study.
    Penne EL; Blankestijn PJ; Bots ML; van den Dorpel MA; Grooteman MP; Nubé MJ; ter Wee PM;
    Semin Dial; 2005; 18(1):47-51. PubMed ID: 15663765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications.
    Courbon F; Caselles O; Zerdoud S; Duthil P; Regis H; Berry I; Caron P
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):363-70. PubMed ID: 17043635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS).
    Bragg-Gresham JL; Fissell RB; Mason NA; Bailie GR; Gillespie BW; Wizemann V; Cruz JM; Akiba T; Kurokawa K; Ramirez S; Young EW
    Am J Kidney Dis; 2007 Mar; 49(3):426-31. PubMed ID: 17336704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Daily" dialysis--lessons from a randomized, controlled trial.
    Twardowski ZJ; Misra M
    N Engl J Med; 2010 Dec; 363(24):2363-4. PubMed ID: 21091061
    [No Abstract]   [Full Text] [Related]  

  • 56. [Dialysis encephalopathy in chronic renal failure].
    Markiewicz K; Bubiński R
    Pol Tyg Lek; 1980 Jul; 35(30):1159-62. PubMed ID: 7001402
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacokinetics of ofloxacin in patients with severe renal impairment].
    Bandai H; Tsubakihara Y; Yamato E; Yokoyama K; Okada N; Nakanishi I; Iida N
    Nihon Jinzo Gakkai Shi; 1987 Nov; 29(11):1429-33. PubMed ID: 3482706
    [No Abstract]   [Full Text] [Related]  

  • 58. Daily dialysis, nocturnal dialysis, and randomized controlled trials: are we asking the right questions?
    Piccoli GB; Magnano A; Perrotta L; Piccoli G
    Kidney Int; 2005 Dec; 68(6):2913-4; author reply 2914. PubMed ID: 16316380
    [No Abstract]   [Full Text] [Related]  

  • 59. [Anatomopathological meeting: intracranial hemorrhage in a patient on chronically dialysis maintenance].
    Medicina (B Aires); 2000; 60(5 Pt 1):615-22. PubMed ID: 11188905
    [No Abstract]   [Full Text] [Related]  

  • 60. The eternal (nocturnal) quest for better dialysis outcomes.
    Kuhlmann MK
    J Am Soc Nephrol; 2012 Apr; 23(4):571-3. PubMed ID: 22423014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.